Topical microemulsion of diosmetin and uses thereof
TN2013000205A1
ORALLY ADMINISTERED PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF, FOR THE PREVENTION AND TREATMENT OF IRRITABLE BOWEL SYNDROME, COMPRISING AN INTESTINAL MOTILITY MODIFIER AND α-D-GALACTOSIDASE
TN2013000197A1
Orally administered pharmaceutical composition for the treatment of irritable bowel syndrome, comprising an intestinal motility modifier, an agent that prevents gas retention, and digestive enzymes, and preparation method thereof
MX2010012480A
Pharmaceutical composition adapted to be orally administered and process for preparing the same for preventing and treating the irritable bowel syndrome by means of an intestinal motility modifier and a-d-galactosidase.
MX2010012479A
Oral pharmaceutical composition for treating the irritable bowel syndrome, which is based on an intestinal motility modifier, an agent for preventing gases from being retained and digestive enzymes and process for the preparation thereof.
CN102056611A
Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
